SD Biosensor Inc
KRX:137310
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7 880
14 850
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
SD Biosensor Inc
Balance Sheet
Balance Sheet Decomposition
SD Biosensor Inc
| Current Assets | 928.2B |
| Cash & Short-Term Investments | 532.5B |
| Receivables | 126.1B |
| Other Current Assets | 269.7B |
| Non-Current Assets | 2.8T |
| Long-Term Investments | 307.1B |
| PP&E | 571.8B |
| Intangibles | 1.9T |
| Other Non-Current Assets | 32.3B |
| Current Liabilities | 159.3B |
| Accounts Payable | 47.6B |
| Accrued Liabilities | 9.3B |
| Other Current Liabilities | 102.4B |
| Non-Current Liabilities | 704.9B |
| Long-Term Debt | 511.7B |
| Other Non-Current Liabilities | 193.3B |
Balance Sheet
SD Biosensor Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
19 200
|
243 216
|
881 593
|
1 872 944
|
482 383
|
|
| Cash Equivalents |
19 200
|
243 216
|
881 593
|
1 872 944
|
482 383
|
|
| Short-Term Investments |
23 075
|
171 993
|
898 228
|
197 027
|
75 334
|
|
| Total Receivables |
28 347
|
441 240
|
391 486
|
118 002
|
153 160
|
|
| Accounts Receivables |
27 432
|
380 781
|
209 168
|
109 014
|
144 471
|
|
| Other Receivables |
915
|
60 459
|
182 317
|
8 988
|
8 689
|
|
| Inventory |
34 309
|
366 364
|
353 248
|
254 663
|
195 621
|
|
| Other Current Assets |
2 643
|
66 448
|
82 233
|
74 630
|
58 471
|
|
| Total Current Assets |
107 575
|
1 289 261
|
2 606 788
|
2 517 266
|
964 970
|
|
| PP&E Net |
50 138
|
115 250
|
207 128
|
468 635
|
551 500
|
|
| PP&E Gross |
50 138
|
115 250
|
0
|
468 635
|
551 500
|
|
| Accumulated Depreciation |
22 102
|
28 530
|
0
|
72 594
|
185 043
|
|
| Intangible Assets |
510
|
651
|
2 724
|
23 366
|
728 677
|
|
| Goodwill |
5 064
|
4 867
|
35 320
|
44 004
|
1 211 637
|
|
| Note Receivable |
226
|
949
|
1 033
|
2 771
|
3 650
|
|
| Long-Term Investments |
708
|
8 075
|
148 357
|
153 904
|
302 633
|
|
| Other Long-Term Assets |
5 498
|
42 598
|
32 584
|
51 978
|
25 765
|
|
| Other Assets |
5 064
|
4 867
|
35 320
|
44 004
|
1 211 637
|
|
| Total Assets |
169 719
N/A
|
1 461 651
+761%
|
3 033 933
+108%
|
3 261 922
+8%
|
3 788 831
+16%
|
|
| Liabilities | ||||||
| Accounts Payable |
11 992
|
429 329
|
134 631
|
45 251
|
31 875
|
|
| Accrued Liabilities |
486
|
23 633
|
5 495
|
9 376
|
8 343
|
|
| Short-Term Debt |
11 381
|
1 694
|
0
|
450
|
450
|
|
| Current Portion of Long-Term Debt |
413
|
4 267
|
6 590
|
12 607
|
135 970
|
|
| Other Current Liabilities |
4 635
|
230 479
|
633 153
|
229 296
|
144 120
|
|
| Total Current Liabilities |
28 907
|
689 402
|
779 869
|
296 980
|
320 758
|
|
| Long-Term Debt |
2 785
|
14 536
|
18 378
|
11 729
|
467 533
|
|
| Deferred Income Tax |
0
|
0
|
0
|
5
|
147 194
|
|
| Minority Interest |
4 510
|
9 530
|
12 858
|
2 480
|
7 887
|
|
| Other Liabilities |
113
|
161
|
3 477
|
6 428
|
21 800
|
|
| Total Liabilities |
36 314
N/A
|
713 630
+1 865%
|
814 582
+14%
|
317 621
-61%
|
965 171
+204%
|
|
| Equity | ||||||
| Common Stock |
5 185
|
46 659
|
51 636
|
52 192
|
62 239
|
|
| Retained Earnings |
9 462
|
625 083
|
1 668 702
|
2 382 819
|
1 885 440
|
|
| Additional Paid In Capital |
118 747
|
77 070
|
579 565
|
616 185
|
913 099
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
3 169
|
|
| Treasury Stock |
0
|
0
|
99 644
|
99 691
|
99 691
|
|
| Other Equity |
10
|
791
|
19 092
|
7 202
|
59 404
|
|
| Total Equity |
133 404
N/A
|
748 021
+461%
|
2 219 351
+197%
|
2 944 301
+33%
|
2 823 660
-4%
|
|
| Total Liabilities & Equity |
169 719
N/A
|
1 461 651
+761%
|
3 033 933
+108%
|
3 261 922
+8%
|
3 788 831
+16%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
103
|
103
|
101
|
102
|
122
|
|
You don't have any saved screeners yet
